Process for making non-peg-treated long-circulating liposomes; liposome; non-pegylated long-term liposomal doxorubicin composition; and method

• 1. 脂质代谢型肥胖基因个体化干预组合物及制备方法和系统 [P] . 中国专利： CN105506080A . 2016-04-20
• 2. 用于制备具有最佳化感官特性的微藻粉的富脂质组合物的方法 [P] . 中国专利： CN105451575A . 2016-03-30
• 3. Composition Comprising A Long-Circulating Non-Pegylated Liposomes and Its Manufacture [P] . 韩国专利： KR101171045B1 . 2012-08-03

  机译： 长循环非聚乙二醇化脂质体的组成及其制造

• 4. COMPOSITION COMPRISING A LONG-CIRCULATING NON-PEGYLATED LIPOSOMES AND ITS MANUFACTURE [P] . 韩国专利： KR20110075051A . 2011-07-05

  机译： 包含长循环非PEG化脂质体的组合物及其制备

• 5. Method of manufacture of a composition comprising a saponin liposome in a liposomal formulation submicromÉtrica in Liposomes contain a lÍpido and a Sterol [P] . AR110334A1 . 2019-03-20

  机译： 包含脂质体和甾醇的脂质体中的亚微米脂质体的包含皂苷脂质体的组合物的制备方法

• 1. Preparation of berberine hydrochloride long-circulating liposomes by ionophore A23187-mediated ZnSO_(4)gradient method [J] . Xiang Luo, Jing Li, Ligang Guo, 亚洲药物制剂科学(英文) . 2013,第004期
• 2. Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing [J] . Ming-Ren Toh, Gigi N.C.Chiu 亚洲药物制剂科学(英文) . 2013,第002期
• 3. Enhancement of liposomal stability and cellular drug uptake by incorporating tributyrin into celecoxib-loaded liposomes [J] . Sung Nam Kang, Soon-Seok Hong, Soo-Yeon Kim, 亚洲药物制剂科学(英文) . 2013,第002期
• 4. Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance [J] . Yinghuan Li, Xi Tan, Xuhan Liu, 亚洲药物制剂科学(英文) . 2020,第005期
• 5. Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than Doxil? [J] . Ruoshi Zhang, Yingxi Zhang, Yue Zhang, 亚洲药物制剂科学(英文) . 2020,第003期
• 6. Tumor-Targeted Liposomes: Increased Cytotoxicity of Doxorubicin-Loaded Long-Circulating Liposomes Modified with Anti-Tumor Monoclonal Antibody [C] . Controlled Release Society annual meeting . 2004
• 7. Targeting of biotinylated long-circulating liposomes to human ovarian cancer. [D] . Fan, Chris Zhiming. 2002
• 8. Biweekly rituximab cyclophosphamide vincristine non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high ‘life threat’ impact cardiopathy [O] . Gaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone, -1
• 9. Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high ‘life threat’ impact cardiopathy [O] . Corazzelli, Gaetano, Frigeri, Ferdinando, Arcamone, Manuela, 2011

• 1. 基于稀疏偏最小二乘方法的复发性卵巢癌脂质组学生物标志物的筛选研究 [C] . . 2016年中国生物统计学术年会 . -1
• 2. 乳脂质体制备方法及牛乳极性脂质理化性质的研究 [A] . 程恳 . 2012